LofmarkS, EdlundC, NordCE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis2010; 50(suppl 1):S16–23.
2.
WatskyKL. Acute generalized exanthematous pustulosis induced by metronidazole: the role of patch testing. Arch Dermatol1999; 135:93–4.
3.
KnowlesS, ChoudhuryT, ShearNH. Metronidazole hypersensitivity. Ann Pharmacother1994; 28:325–6.
4.
PearlmanMD, YasharC, EmstS, SolomonW. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole. Am J Obstet Gynecol1996; 174:934–6.
5.
NaranjoCA, BustoU, SellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981-30; 239–45.
6.
KanoY, ShioharaT. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am2009; 29:481–501.
7.
SethD, KamatD, MontejoJ. DRESS syndrome: a practical approach for primary care practitioners. Clin Pediatr (Phila)2008; 47:947–52.
